Yayınlar & Eserler

Yayın Ağı
Makaleler 7
Tümü (7)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (7)
Scopus (7)

1. Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer

Kahraman E. G., ÜNAL O. Ü., TAŞKAYNATAN H., ÖZDEMİR Ö., BUDAK E., SELVER M. A.
BMC Medical Imaging , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

ÖZDEMİR Ö., Günenç D., TAŞKAYNATAN H., Peker P., Kahraman E. G., Biter S., et al.
Journal of Clinical Medicine , cilt.15, sa.10, 2026 (SCI-Expanded, Scopus)

3. Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making †

Kutlu Ö., Günenç D., AYAZ D., ÖZDEMİR Ö., TAŞKAYNATAN H., Akdemir C., et al.
Diagnostics , cilt.15, sa.24, 2025 (SCI-Expanded, Scopus)

4. Prevalence of Insomnia and Associated Factors in Female Patients Undergoing Chemotherapy

TAŞKAYNATAN H., Ersoz B., Camanli U., Gezici B., Arslan Tan F., Mercan K., et al.
Nature and Science of Sleep , cilt.17, ss.2517-2528, 2025 (SCI-Expanded, Scopus) Creative Commons License

5. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Avcı O., İriağaç Y., Çavdar E., Karaboyun K., Araz M., Şakalar T., et al.
Journal of Geriatric Oncology , cilt.14, sa.8, 2023 (SCI-Expanded, Scopus)

6. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Erol C., ŞENDUR M. A. N., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.
Journal of Cancer Research and Therapeutics , cilt.18, sa.9, ss.347-353, 2022 (SCI-Expanded, Scopus)

7. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

ÖZDEMİR Ö., Zengel B., Yildiz Y., Uluç B. O., ÇABUK D., Ozden E., et al.
Anti-Cancer Drugs , cilt.33, sa.7, ss.663-670, 2022 (SCI-Expanded, Scopus)
Metrikler

Yayın

7

Yayın (WoS)

7

Yayın (Scopus)

7

H-İndeks (WoS)

3

Atıf (Scopus)

23

H-İndeks (Scopus)

3

Tez Danışmanlığı

1

Açık Erişim

1